Roivant Sciences Ltd
ROIVLatest QuantConomy context for ROIV: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Roivant Sciences Ltd
QuantConomy has a structured record for ROIV. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ROIV
- Name
- Roivant Sciences Ltd
- Coverage
- 3 market/data records
- Sources
- alpaca fmp alphavantage sec nasdaq
Recent signals for ROIV
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| insider trade cluster sell | bearish | 68 | Jul 1, 02:51 AM | Cluster selling detected: 3 insider trades for ROIV worth $30.61M total - 300,783 shares - [strong bearish signal] |
| insider trade large sale | bearish | 48 | Jul 1, 01:01 AM | Gold Daniel Allen (Director) sold ROIV shares ($10.20M) - 300,783 shares - [weak bearish signal] |
| insider trade large sale | slightly bearish | 30 | Jul 1, 12:00 AM | QVT Financial LP sold ROIV shares ($10.20M) - 300,783 shares - [very weak slightly bearish signal] |
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ROIV | NASDAQ | alpaca | Roivant Sciences Ltd. Common Shares |
| ROIV | NASDAQ | fmp | Roivant Sciences Ltd. |
| ROIV | NASDAQ | alphavantage | Roivant Sciences Ltd |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Gline Matthew | CEO | other | 76,171 | $35.39 | $2,695,692 | 4 on EDGAR |
| Jun 30, 2026 | Fitzgerald Meghan | Insider | exercise | 10,000 | $8.80 | $88,000 | 4 on EDGAR |
| Jun 30, 2026 | Sukhatme Mayukh | President & CIO | other | 46,878 | $35.39 | $1,659,012 | 4 on EDGAR |
| Jun 30, 2026 | Torti Frank | President and Vant Chair | other | 40,310 | $35.39 | $1,426,571 | 4 on EDGAR |
| Jun 29, 2026 | Epperly Melissa B, | Insider | exercise | 17,750 | $4.46 | $79,165 | 4 on EDGAR |
| Jun 26, 2026 | Gold Daniel Allen | Director | sale | 300,783 | $33.92 | $10,202,559 | 4 on EDGAR |
| Jun 26, 2026 | QVT Financial LP | Insider | sale | 300,783 | $33.92 | $10,202,559 | 4 on EDGAR |
| Jun 26, 2026 | MANCHESTER KEITH S | Director | sale | 300,783 | $33.92 | $10,202,559 | 4 on EDGAR |
| Jun 24, 2026 | Venker Eric | President & Immunovant CEO | exercise | 200,000 | $3.85 | $770,000 | 4 on EDGAR |
| Jun 20, 2026 | Pulik Richard | CFO | other | 2,129 | $31.43 | $66,914 | 4 on EDGAR |
| Jun 20, 2026 | Humes Jennifer | Chief Accounting Officer | other | 3,582 | $31.43 | $112,582 | 4 on EDGAR |
| May 20, 2026 | Venker Eric | President & Immunovant CEO | other | 34,483 | $32.41 | $1,117,594 | 4 on EDGAR |
| May 20, 2026 | Pulik Richard | CFO | other | 18,962 | $32.41 | $614,558 | 4 on EDGAR |
| Apr 20, 2026 | Venker Eric | President & Immunovant CEO | exercise | 200,000 | $3.85 | $770,000 | 4 on EDGAR |
| Apr 20, 2026 | Pulik Richard | CFO | grant | 60,644 | $0.00 | $0 | 4 on EDGAR |
| Apr 20, 2026 | Humes Jennifer | Chief Accounting Officer | grant | 29,173 | $0.00 | $0 | 4 on EDGAR |
| Apr 17, 2026 | Epperly Melissa B, | Insider | grant | 670 | $0.00 | $0 | 4 on EDGAR |
| Apr 17, 2026 | MOMTAZEE JAMES C | Insider | grant | 469 | $0.00 | $0 | 4 on EDGAR |
| Apr 17, 2026 | Oren Ilan | Director | grant | 896 | $0.00 | $0 | 4 on EDGAR |
| Apr 16, 2026 | Gline Matthew | CEO | sale | 289,774 | $29.16 | $8,449,810 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ROIV context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access